Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

Published Date: 18 Oct 2025

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

2.

Getting ahead of head and neck cancer

3.

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

4.

No increased risk of childhood cancer near UK nuclear sites, study finds

5.

Nasal therapeutic HPV vaccine could prevent cervical cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot